Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Characterizing and explaining the impact of disease-associated mutations in proteins without known structures or structural homologs
2022 StandoutNobel
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
The PHQ-8 as a measure of current depression in the general population
2008 Standout
Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk
2006
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
2002 Standout
Association between Serum Lipids and Survival in Hemodialysis Patients and Impact of Race
2006
Acute kidney injury
2012 Standout
Complement and its role in innate and adaptive immune responses
2009 Standout
Oral Phosphate Binders in Patients with Kidney Failure
2010
Autoimmune forms of thrombotic micorangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles
2009
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability
2010
Albumin turnover: experimental approach and its application in health and renal diseases
2004
Modification of cardiovascular risk in hemodialysis patients: An evidence‐based review
2007
Autoinflammatory Disease Reloaded: A Clinical Perspective
2010 Standout
Fistula First Is Not Always the Best Strategy for the Elderly
2013
Hemolytic uremic syndrome recurrence after renal transplantation
2008
Estimating the Total Incidence of Kidney Failure in Australia Including Individuals Who Are Not Treated by Dialysis or Transplantation
2012
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
2011 Standout
Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia
2004
The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review
2010 Standout
Re-evaluating the Fistula First Initiative in Octogenarians on Hemodialysis
2011
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
Dialysis delayed is death prevented: A clinical perspective on the RENAAL study
2003
Complement in human diseases: Lessons from complement deficiencies
2009
Atypical Hemolytic–Uremic Syndrome
2009
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Chronic kidney disease
2011 Standout
Biological roles of glycans
2016 Standout
Sensors of the innate immune system: their link to rheumatic diseases
2010 StandoutNobel
Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae
2016
Statins for Improving Renal Outcomes
2006
Therapeutic Strategies for Heart Failure in Cardiorenal Syndromes
2010
Premature cardiovascular disease in chronic renal failure
2000
Cardiorenal Syndrome
2008 Standout
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
2019
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Diabetes and Atherosclerosis
2002 Standout
Lipid-lowering therapy in patients with renal disease
1995
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis
2011
Structure of complement fragment C3b–factor H and implications for host protection by complement regulators
2009
Worldwide access to treatment for end-stage kidney disease: a systematic review
2015 Standout
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Statins, inflammation and kidney disease
2011
Atherosclerosis
2019 Standout
The impact of the assay for measuring albumin on corrected ('adjusted') calcium concentrations
2009
Long-term outcome on renal replacement therapy in patients who previously received a keto acid–supplemented very-low-protein diet
2009
La pharmacopée de prévention cardiovasculaire est-elle sous-utilisée chez les patients souffrant d’insuffisance rénale chronique après un infarctus du myocarde ?
2010
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Use of magnesium as a drug in chronic kidney disease
2012
Identification of discriminative gene-level and protein-level features associated with pathogenic gain-of-function and loss-of-function variants
2021
The Role of Oxidative Stress–Altered Lipoprotein Structure and Function and Microinflammation on Cardiovascular Risk in Patients with Minor Renal Dysfunction
2004
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Should the Arteriovenous Fistula Be Created before Starting Dialysis?: A Decision Analytic Approach
2011
Chronic Kidney Disease
2016 Standout
Simvastatin
1995
Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes
2011 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Metabolic modes of action of the statins in the hyperlipoproteinemias
1998
Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: A randomised, double‐blind clinical trial
2006
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Early recognition and prevention of chronic kidney disease
2010
Conservative Management of End-Stage Renal Disease without Dialysis: A Systematic Review
2012
Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
2009
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
2011
Raman spectroscopic screening of high and low molecular weight fractions of human serum
2019
Magnesium in Man: Implications for Health and Disease
2014 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
2010
HMG CoA reductase inhibitors (statins) for kidney transplant recipients
2014
The Tumor Lysis Syndrome
2011 Standout
Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease
2012
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease
2012
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Complement System Part II: Role in Immunity
2015
Biodegradable polymers as biomaterials
2007 Standout
Evaluating non-randomised intervention studies
2003 Standout
Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies
2019 StandoutNobel
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates
2012
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Dialysis Access: An Increasingly Important Clinical Issue
2009
Re-envisioning Fistula First in a Patient-Centered Culture
2013
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
2014
An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and Wales
2005
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
2014
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
2009 Standout
Differentiation of Effector CD4 T Cell Populations
2010 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis
2017
Works of Graham Warwick being referenced
Why do patients known to renal services still undergo urgent dialysis initiation? A cross-sectional survey
2007
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
2005 StandoutNobel
Albumin as an outcome measure in haemodialysis in patients: the effect of variation in assay method
2000
The Second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: A Randomized Controlled Study of the Biochemical Safety and Efficacy of Adding Ezetimibe to Simvastatin as Initial Therapy Among Patients With CKD
2006
Mutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome
2005
Outcome of renal replacement therapy in the very elderly
2001
A simultaneous study of the metabolism of apolipoprotein B and albumin in nephrotic patients
1998
Analysis of Patients Dying within One Year of Starting Renal Replacement Therapy
2000
Iron-Magnesium Hydroxycarbonate (Fermagate)
2009
Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria
1991
Serum calcium, phosphate, parathyroid hormone, albumin, aluminium and cholesterol achievement on replacement therapy (Chapter 9)
2007
Primary Hyperlipidaemia is Not Associated with Increased Urinary Albumin Excretion
1991
Chapter 10: Biochemistry Profile of Patients Receiving Dialysis in the UK in 2008: national and centre-specific analyses
2010
Lipoprotein metabolism in the nephrotic syndrome
1993
Effect of simvastatin on plasma lipid and lipoprotein concentrations and low-density lipoprotein metabolism in the nephrotic syndrome
1992
A Successful Scheme for Reducing Waiting Times for Arteriovenous Fistula Formation
2008